# 24hr Imaging Of HCC After EOVIST

> **NCT01968629** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Eovist

## Key facts

- **NCT ID:** NCT01968629
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-12
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No eligible subject enrolled
- **Last updated:** 2015-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968629, "24hr Imaging Of HCC After EOVIST". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01968629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*